NEW YORK, NY — In a novel approach to conquering HIV, amfAR, The Foundation for AIDS Research, is pairing HIV researchers with bioengineers to address the main barrier to a cure for HIV: the persistent reservoirs of virus not cleared by antiretroviral therapy. A new round of Investment grants, totaling $1.2 million, will support six…
NEW YORK – amfAR, The Foundation for AIDS Research, today announced the beta launch of its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFAR’s planned funding of HIV/AIDS activities from 2007 to 2014. The database was unveiled at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015)…
NEW YORK, N.Y.— amfAR, The Foundation for AIDS Research will return to Brazil for its fifth annual Inspiration Gala São Paulo presented by Harry Winston. The gala will again be held at the home of Dinho Diniz, hosted by Naomi Campbell and will feature tributes to Felipe Diniz and Jean Paul Gaultier. Diniz, who will receive the amfAR Inspiration Award, has been vital to the success of amfAR’s…
NEW YORK, N.Y., – amfAR, The Foundation for AIDS Research, has announced that it has created a $100 million investment strategy in support of its Countdown to a Cure for AIDS initiative, launched last year with the aim of developing the scientific basis of a cure by 2020. The establishment of the amfAR Institute for…
NEW YORK – Despite important price reductions for some low- and middle-income countries, the exorbitant drug pricing of breakthrough treatments for hepatitis C (HCV) infection will inevitably limit access to the drugs, leading to unnecessary loss of life, according to a new report from amfAR, The Foundation for AIDS Research. While the new drugs have…
